Indeed, a positive feedback loop between MYCN and the HDAC SIRT1 has been described, and treatment with the SIRT1 inhibitor cambinol was able to reduce tumorigenesis in the transgenic NB model [72]. This evidence concerns the gene HDAC9 and neuroblastoma.